Engineering at the scale of atoms and molecules. Building machines smaller than a human cell. The most extreme miniaturization possible in a physical universe.
One nanometer is one billionth of a meter. A human hair is ~80,000 nm wide. A DNA helix is ~2 nm wide. Nanotechnology operates in the 1–100 nm range — where the rules of classical physics blur into quantum mechanics, where surface area dominates volume, and where properties of materials change dramatically from their bulk counterparts. The field spans drug delivery, computing, materials science, and potentially self-replicating machines.
At the nanoscale, quantum mechanical effects dominate. Gold, which is yellow in bulk, appears red or purple as nanoparticles because its optical properties change with size. Carbon arranged as graphite is soft and black — arranged as diamond is the hardest natural material — arranged as a nanotube is 100x stronger than steel at a fraction of the weight.
Cylinders of carbon atoms. Extraordinary mechanical strength, electrical conductivity, and thermal properties. Used in specialized composites. Future applications in computing and structural materials.
Nanoparticles loaded with drugs that specifically target cancer cells, releasing medication only at the tumor site. Reduces side effects dramatically. Already in clinical use.
COVID-19 vaccines use lipid nanoparticles to deliver mRNA into cells. This is nanotechnology that vaccinated billions of people. The delivery mechanism is nano-engineering.
Modern CPU transistors are ~3-5nm — a few dozen atoms across. This IS nanotechnology, built by the semiconductor industry. Your phone processor is a nanotech device.
Atomic Force Microscopes and Scanning Tunneling Microscopes can image and move individual atoms. IBM spelled their logo in xenon atoms in 1989 — the first deliberate nanoscale manipulation.
Using DNA as a programmable building material — folding it into arbitrary 2D and 3D shapes with nanometer precision. Being developed as scaffolding for nano-devices and drug delivery vehicles.
The theoretical vision: autonomous nanoscale machines that navigate the bloodstream, identify diseased cells, deliver drugs, perform mechanical repairs, and report back — essentially creating a programmable immune system augmentation. This is not current technology, but the building blocks are being assembled.
Current progress: researchers have demonstrated DNA-based "nanorobots" that can carry a drug payload and open it only when they encounter a specific molecular signal (like a cancer biomarker). These aren't autonomous — they're programmed molecular machines — but they demonstrate the principle works.